Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 26.82M | 14.94M | 8.69M | 11.04M | 7.75M | 5.24M |
Gross Profit | 6.94M | 3.47M | -3.34M | 2.00M | 838.61K | 205.70K |
EBITDA | 90.80K | -1.29M | -5.89M | 1.28M | 832.88K | -2.38M |
Net Income | -882.35K | -1.73M | -6.35M | 428.66K | -60.47K | -3.29M |
Balance Sheet | ||||||
Total Assets | 47.50M | 34.64M | 28.09M | 34.70M | 35.00M | 13.30M |
Cash, Cash Equivalents and Short-Term Investments | 6.97M | 18.17M | 11.97M | 19.32M | 21.62M | 919.31K |
Total Debt | 844.99K | 1.08M | 28.44K | 312.00K | 215.15K | 629.83K |
Total Liabilities | 9.99M | 6.04M | 2.57M | 2.83M | 2.63M | 6.11M |
Stockholders Equity | 37.51M | 28.60M | 25.52M | 31.87M | 32.37M | 7.19M |
Cash Flow | ||||||
Free Cash Flow | -8.44M | 1.79M | -6.28M | -1.98M | -3.08M | -1.55M |
Operating Cash Flow | -767.65K | 2.22M | -4.75M | -249.28K | -2.43M | -1.31M |
Investing Cash Flow | -17.33M | -42.07K | -1.34M | -1.79M | -653.13K | -243.09K |
Financing Cash Flow | 11.46M | 4.14M | -1.07M | -267.73K | 23.78M | 2.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | $1.87B | ― | -3.27% | ― | 178.66% | 82.83% | |
58 Neutral | $951.79M | ― | -12.38% | 1.07% | -8.59% | -256.43% | |
55 Neutral | $745.63M | ― | -9.63% | 1.86% | 8.66% | 66.06% | |
50 Neutral | $793.28M | ― | -70.82% | ― | 1148.97% | 35.59% |
On October 19, 2025, United States Antimony Corporation announced a proposal to acquire 100% of Larvotto Resources Limited, an Australian company, through a scheme of arrangement. This acquisition aims to create one of the largest antimony producers outside China, offering Larvotto shareholders a significant premium and the chance to be part of a more diversified group. USAC has already acquired 10% of Larvotto’s shares and sees this move as a strategic fit to enhance its position in the critical minerals industry.
The most recent analyst rating on (UAMY) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
On October 17, 2025, United States Antimony Corporation announced the filing of a prospectus supplement with the SEC, allowing for the offer and sale of up to $400 million in common stock. This move, facilitated by an agreement with A.G.P./Alliance Global Partners and B. Riley Securities, Inc., is part of the company’s strategy to enhance its financial position and operational capabilities.
The most recent analyst rating on (UAMY) stock is a Hold with a $13.50 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
On October 6, 2025, United States Antimony Corporation entered into a Securities Purchase Agreement with an institutional investor to sell 3,500,000 shares of common stock at $7.50 per share, raising approximately $26.25 million. The company also adjusted its ATM Prospectus Supplement, reducing the offering from $65 million to $39.885 million, allowing for additional sales of up to $30.109 million in common stock.
The most recent analyst rating on (UAMY) stock is a Buy with a $8.50 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
On September 17, 2025, United States Antimony Corporation amended its sales agreement to include B. Riley Securities as an additional sales agent alongside A.G.P./Alliance Global Partners. This amendment allows the company to sell shares of its common stock through an at-the-market offering, with specific parameters set for the sales. The company also filed a prospectus supplement to increase the amount of shares issuable to up to $65,000,000, enhancing its ability to raise capital.
The most recent analyst rating on (UAMY) stock is a Buy with a $4.50 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
United States Antimony Corporation completed its reincorporation from Montana to Texas on August 28, 2025, following approval by stockholders at the 2025 Annual Meeting. The reincorporation, effective August 13, 2025, involved adopting new bylaws and did not alter the company’s business operations, management, or financial condition, although certain stockholder rights were changed.
The most recent analyst rating on (UAMY) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.
United States Antimony Corp. recently held its earnings call, revealing a generally positive sentiment driven by strong financial performance and growth in its antimony and zeolite businesses. Despite these successes, the company faces challenges, including regulatory delays in Alaska and quality issues with a supplier, which have impacted operations.
United States Antimony Corporation, a company involved in the processing and sale of antimony, zeolite, and precious metals, operates primarily in the U.S. and Canada, with facilities in Montana and Mexico. The company has reported significant financial growth in the first half of 2025, with revenues increasing by 160% year-over-year to $17.53 million and net income rising by 707% to $728,000. This growth is largely attributed to a 203% increase in antimony sales, driven by higher average sales prices. The company also made strategic investments, including a $5 million acquisition of a tungsten mining operation in Canada. Despite challenges such as suboptimal ore supply and staffing issues, US Antimony has resolved these problems and expects improved performance in the latter half of the year. The company is focused on increasing production capacity and securing additional antimony supplies to meet its revenue guidance of $40 to $50 million for 2025.
At the 2025 Annual Shareholders Meeting held on July 31, United States Antimony Corporation successfully passed all proposals, including the election of directors and the approval of the company’s reincorporation from Montana to Texas. The meeting also ratified the appointment of Assure CPA, LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, indicating a strategic shift and operational continuity for the company.
The most recent analyst rating on (UAMY) stock is a Buy with a $1.00 price target. To see the full list of analyst forecasts on United States Antimony stock, see the UAMY Stock Forecast page.